Targeting RGS4 Ablates Glioblastoma Proliferation

Glioblastoma (GBM) is the most common type of adult primary brain tumor with a median survival rate of less than 15 months, regardless of the current standard of care. Cellular heterogeneity, self-renewal ability and tumorigenic glioma cancer stem cell (GSC) populations contribute to the difficulty...

Descripción completa

Detalles Bibliográficos
Autores principales: Guda, Maheedhara R., Velpula, Kiran K., Asuthkar, Swapna, Cain, Charlie P., Tsung, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247588/
https://www.ncbi.nlm.nih.gov/pubmed/32392739
http://dx.doi.org/10.3390/ijms21093300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247588/
https://www.ncbi.nlm.nih.gov/pubmed/32392739
http://dx.doi.org/10.3390/ijms21093300

Ejemplares similares